An update on migraine guidelines: Integrating new therapies for better outcomes

Dr Monteith discusses new guidelines on migraine treatment, and how to integrate new treatments for better outcomes. 

Dr Monteith discloses consulting fees, or paid advisory boards, from Impel NeuroPharma, Lundbeck, Alder Pharmaceuticals, and Amgen Pharmaceuticals.